Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
Classifica tra le azioni
#4940
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally... Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
Prezzo delle azioni
$2.47
Capitalizzazione di mercato
$2.95B
Variazione (1 giorno)
0.18%
Variazione (1 anno)
-14.53%
Paese
CN
Scambia Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Categoria
Healthcare
Rapporto P/B per Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Rapporto P/B al October 2026 TTM: 0.60
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Jilin Aodong Pharmaceutical Group Co., Ltd., il rapporto P/B attuale (TTM) è 0.60. Alla fine del 2023, era pari a 0.63.
Storico del rapporto P/B per Jilin Aodong Pharmaceutical Group Co., Ltd. da 2000 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2026 (TTM) | 0.60 | -13.67% |
| 2024 | 0.70 | 11.71% |
| 2023 | 0.63 | -4.03% |
| 2022 | 0.65 | -22.83% |
| 2021 | 0.85 | 3.64% |
| 2020 | 0.82 | -5.45% |
| 2019 | 0.86 | 8.73% |
| 2018 | 0.79 | -38.62% |
| 2017 | 1.29 | -11.82% |
| 2016 | 1.47 | -7.84% |
| 2015 | 1.59 | -35.53% |
| 2014 | 2.47 | 63.97% |
| 2013 | 1.51 | -4.54% |
| 2012 | 1.58 | 1.57% |
| 2011 | 1.55 | -42.84% |
| 2010 | 2.72 | -39.78% |
| 2009 | 4.51 | 103.81% |
| 2008 | 2.21 | -73.01% |
| 2007 | 8.20 | 53.64% |
| 2006 | 5.34 | 362.58% |
| 2005 | 1.15 | -5.59% |
| 2004 | 1.22 | 8.05% |
| 2003 | 1.13 | -35.55% |
| 2002 | 1.76 | -6.22% |
| 2001 | 1.87 | -38.50% |
| 2000 | 3.04 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 734.19% |
IN
|
